Role of organelle pH in tumor cell biology and drug resistance - PubMed (original) (raw)
Role of organelle pH in tumor cell biology and drug resistance
SM Simon. Drug Discov Today. 1999 Jan.
Abstract
Multidrug resistance is a generic term for the variety of strategies that tumor cells develop to evade the cytotoxic effects of anticancer drugs. It is characterized by decreased cellular sensitivity, not only to the drug(s) employed in chemotherapy but also to a broad spectrum of drugs with neither obvious common targets nor structural homology. It is one of the major obstacles to the successful treatment of tumors. This review concentrates on some of the physiological changes observed in drug-sensitive and drug-resistant tumor cell lines that could account for their relative sensitivities to chemotherapeutics. These changes suggest alternative strategies for combating tumor cells in general and multidrug-resistant cells in particular.
Similar articles
- The multiple mechanisms of multidrug resistance and cellular pH.
Simon S. Simon S. Novartis Found Symp. 2001;240:269-81; discussion 282-9. doi: 10.1002/0470868716.ch19. Novartis Found Symp. 2001. PMID: 11727935 Review. - Cell biological mechanisms of multidrug resistance in tumors.
Simon SM, Schindler M. Simon SM, et al. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3497-504. doi: 10.1073/pnas.91.9.3497. Proc Natl Acad Sci U S A. 1994. PMID: 7909602 Free PMC article. - Engineering Anticancer Amphipathic Peptide-Dendronized Compounds for Highly-Efficient Plasma/Organelle Membrane Perturbation and Multidrug Resistance Reversal.
Zhang X, Li Y, Hu C, Wu Y, Zhong D, Xu X, Gu Z. Zhang X, et al. ACS Appl Mater Interfaces. 2018 Sep 19;10(37):30952-30962. doi: 10.1021/acsami.8b07917. Epub 2018 Aug 22. ACS Appl Mater Interfaces. 2018. PMID: 30088909 - Cytotoxicity of South-African medicinal plants towards sensitive and multidrug-resistant cancer cells.
Saeed MEM, Meyer M, Hussein A, Efferth T. Saeed MEM, et al. J Ethnopharmacol. 2016 Jun 20;186:209-223. doi: 10.1016/j.jep.2016.04.005. Epub 2016 Apr 4. J Ethnopharmacol. 2016. PMID: 27058630 - Physiologic and pathologic drug resistance in ovarian carcinoma--a hypothesis based on a clonal progression model.
Pusztai L, Siddik ZH, Mills GB, Bast RC Jr. Pusztai L, et al. Acta Oncol. 1998;37(7-8):629-40. doi: 10.1080/028418698429964. Acta Oncol. 1998. PMID: 10050979 Review.
Cited by
- Recent progress in tumor pH targeting nanotechnology.
Lee ES, Gao Z, Bae YH. Lee ES, et al. J Control Release. 2008 Dec 18;132(3):164-70. doi: 10.1016/j.jconrel.2008.05.003. Epub 2008 May 10. J Control Release. 2008. PMID: 18571265 Free PMC article. Review. - Silencing bcl-2 expression in epithelial cancer cells using "smart" particles.
Lin YL, Jiang G, Zhang Z, Nör JE, ElSayed ME. Lin YL, et al. J Funct Biomater. 2014 Sep 16;5(3):167-82. doi: 10.3390/jfb5030167. J Funct Biomater. 2014. PMID: 25229941 Free PMC article. - Light induced drug release from a folic acid-drug conjugate.
Dcona MM, Sheldon JE, Mitra D, Hartman MC. Dcona MM, et al. Bioorg Med Chem Lett. 2017 Feb 1;27(3):466-469. doi: 10.1016/j.bmcl.2016.12.036. Epub 2016 Dec 18. Bioorg Med Chem Lett. 2017. PMID: 28040391 Free PMC article. - The effect of environmental pH on polymeric transfection efficiency.
Kang HC, Samsonova O, Kang SW, Bae YH. Kang HC, et al. Biomaterials. 2012 Feb;33(5):1651-62. doi: 10.1016/j.biomaterials.2011.11.006. Epub 2011 Nov 29. Biomaterials. 2012. PMID: 22130563 Free PMC article. - Inhibition of endosomal sequestration of basic anticancer drugs: influence on cytotoxicity and tissue penetration.
Lee CM, Tannock IF. Lee CM, et al. Br J Cancer. 2006 Mar 27;94(6):863-9. doi: 10.1038/sj.bjc.6603010. Br J Cancer. 2006. PMID: 16495919 Free PMC article.